TORONTO, ON--(Marketwired - October 28, 2016) - During a live broadcast on Thursday, November 10 at 11:00am EDT, featured presenters from inVentiv Health will share data collected through a survey of managed market payers in the United States, and the potential issues and insights revealed at its ASCO 2016 Roundtable with Pharmaceutical Executive. Also included will be recommendations for how the industry will move forward to overcome the obstacles in the path of acceptance of PRO as an appropriate measure of the patient's voice in cancer care.
Learning Objectives for this free 60-minute webinar:
- Learn about payer perspectives on patient reported outcomes
- Identify potential conflicts caused by discordance between current payer perspectives towards PRO and other industry trends in favor of PRO
- Identify potential strategies for increasing the acceptance of PRO measures in clinical trials and drug evaluation.
Patient-reported outcomes (PRO) promise better information on the patient's actual experience in drug trials and treatment, and they are now receiving close attention from regulators, industry, and patient advocates.
In May of 2016, inVentiv Health conducted a survey of managed market payers in the United States on the potential value of PRO in the evaluation of drugs. Despite the current focus on PRO including editorials in New England Journal of Medicine, Journal of Clinical Oncology, and JAMA Oncology, those surveyed express overt ambivalence about PRO as a decision-making tool, even in costly, hard-to-treat cancers. The full potential of a drug evaluation model that incorporates insights on the real-life patient experience hangs in the balance.
A follow-up roundtable, sponsored by Pharmaceutical Executive, was conducted to discuss the results of this survey in Chicago at the ASCO 2016 Annual Meeting. The discussions there revealed that leaders representing different segments of the industry were disappointed, but not surprised, by the survey results. Patients may not feel the issues that matter to them are acknowledged in the information hierarchy that dominates clinical decisions. Industry builds PRO data instruments with exhaustive patient input and focuses on collecting more than 85% complete data, yet payers feel that this data is spotty, inconsistent, and lacking impact on the costs of care. Thus the onus is on all of those entrusted with the execution of modern clinical trials-including regulators, industry, as well as the patient-to make the case for PRO through greater methodological clarity and better alignment with safety, efficacy, and other data assessment approaches like patient registries. If PRO can be effectively used to fully characterize the impact of new therapies, they will have a greater acceptance in drug evaluation by payers.
To learn more or register for this complimentary event, visit Xtalks' website: Patient Centered Strategies for Clinical Trials & Treatment: Reactions to Payer Perspectives on Patient Reported Outcomes.
About inVentiv Health
inVentiv Health is a global professional services organization designed to help the biopharmaceutical industry accelerate the delivery of much-needed therapies to market. Our combined Clinical Research Organization (CRO) and Contract Commercial Organization (CCO) offer a differentiated suite of services, processes and integrated solutions that improve client performance. With more than 15,000 employees and the ability to support clients in 90 countries, our global scale and deep therapeutic expertise enable inVentiv to help clients successfully navigate an increasingly complex environment. For more information, visit inVentivHealth.com.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, health care centers, etc.) turn to Xtalks for access to quality content. Xtalks helps life science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com.
For information about hosting a webinar, visit http://xtalks.com/sponsorship.ashx.
Image Available: http://www.marketwire.com/library/MwGo/2016/10/27/11G119746/Images/inVentivHealth_Center_RGB_NEW2016-4bbcca72a81d9e6b992aa648cbd67297.jpg